Children's Mercy Physician Leads Effort to Update American Academy of Pediatrics Off-Label Pharmaceuticals Policy - WECT TV6-WECT.com:News, weather & sports Wilmington, NC

Children's Mercy Physician Leads Effort to Update American Academy of Pediatrics Off-Label Pharmaceuticals Policy

  • HealthMore>>

  • FDA to propose e-cigarette regulations

    FDA to propose e-cigarette regulations

    © FDA© FDA
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
  • People seek out health info when famous person dies

    People seek out health info when famous person dies

    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
  • 1 in 13 U.S. schoolkids takes psych meds

    1 in 13 U.S. schoolkids takes psych meds

    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>
    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Children's Mercy

Policy statement suggests ways to improve drug safety and efficacy in children, aligning with mission of Children's Mercy to improve patient outcomes

KANSAS CITY, Mo., Feb. 24, 2014 /PRNewswire/ -- With less than half of medications including specific labeling for children, Kathleen Neville, MD, MS, a physician at Children's Mercy Hospital, recently led an American Academy of Pediatrics (AAP) committee in updating the policy with new recommendations guiding the off-label use of drugs in pediatric patients. The policy statement, "Off-Label Use of Drugs in Children," was published online today in the March 2014 issue of Pediatrics.

Children's Mercy

Dr. Neville is chair of the AAP Committee on Drugs and Director of Experimental Therapeutics in Pediatric Cancer at Children's Mercy. The AAP statement offers guidance to physicians using drugs off-label in the treatment of children, particularly in special populations, including preterm infants and newborns, and those with chronic or rare diseases.

The policy statement updates guidance from nearly a decade ago that resulted in more than 500 labeling changes, including expanded labeling with pediatric information.

"Our goal is to provide children with the best care possible, and scientific evidence remains the best way to make treatment decisions," said Dr. Neville. "There's still much work to be done. Ultimately, all drugs used to treat children should have sufficient age-appropriate evidence to support updated labeling."

Experimental Therapeutics at Children's Mercy

Children's Mercy has the largest and most productive pediatric clinical pharmacology program in North America. The program pairs clinicians who identify clinically significant medication-related problems with basic science faculty members who have the expertise necessary to solve them.

Under the direction of Dr. Neville, the Experimental Therapeutics in Pediatric Cancer Program is quickly gaining recognition as a regional referral center, giving children with recurrent or refractory cancer a local option to pursue experimental treatment with early-phase anti-cancer drugs. Neville has had extensive training in experimental therapeutics for children with cancer, and is leading Phase I research efforts to develop new agents for the treatment of pediatric cancer and supportive care for patients.

In collaboration with the Institute for Advancing Medical Innovation (AMI) and the National Institutes of Health (NIH), the team has begun screening compounds, identifying several that appear promising as potential drug development candidates. The program is currently involved in more than 15 Phase I and Phase II trials.

About Children's Mercy

Children's Mercy, located in Kansas City, Mo., is one of the nation's top pediatric medical centers. The 354-bed hospital provides care for children from birth through the age of 21, and has been ranked by U.S. News & World Report as one of "America's Best Children's Hospitals." For the third time in a row, Children's Mercy has achieved Magnet nursing designation, awarded to fewer than seven percent of all hospitals nationally, for excellence in quality care. Its faculty of 600 pediatricians and researchers across more than 40 subspecialties are actively involved in clinical care, pediatric research, and educating the next generation of pediatric subspecialists. For more information about Children's Mercy and its research, visit childrensmercy.org or download our mobile phone app CMH4YOU for all phone types. For breaking news and videos, follow us on Twitter, YouTube and Facebook.

Logo: http://photos.prnewswire.com/prnh/20130904/NY73838LOGO

 

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow